E2 ModeratePreliminaryPEM ?Cross-SectionalPeer-reviewedMachine draft
[Demonstration on Borna disease virus in patients with chronic fatigue syndrome].
Nakaya, T, Kuratsune, H, Kitani, T et al. · Nihon rinsho. Japanese journal of clinical medicine · 1997
Quick Summary
Researchers tested whether a virus called Borna disease virus (BDV) might be connected to ME/CFS. They found that some patients with ME/CFS had signs of BDV infection, and the virus was also detected in one family where multiple members had ME/CFS. While these findings suggest BDV could play a role, the study shows it's likely not the sole cause of ME/CFS.
Why It Matters
Understanding potential viral triggers of ME/CFS is crucial for developing targeted diagnostic and therapeutic approaches. If viruses like BDV contribute to ME/CFS pathogenesis, this could explain disease heterogeneity and guide antiviral research strategies. Identifying biomarkers of viral infection may help stratify patient populations for better treatment outcomes.
Observed Findings
- BDV antibodies detected in 34% of CFS patients (30/89) by immunoblotting
- BDV RNA detected in 12% of CFS patients (7/57) by PCR
- Anti-BDV antibodies and viral RNA identified in a familial cluster of CFS cases
- BDV is a neurotropic RNA virus with reported associations to depression and schizophrenia
Inferred Conclusions
- BDV may contribute to or initiate CFS in some patients
- BDV alone is unlikely to be the single etiologic agent of CFS
- The presence of BDV in family clusters suggests possible viral transmission in familial CFS cases
Remaining Questions
- Does BDV prevalence differ between CFS patients and matched healthy controls?
- What is the mechanistic pathway by which BDV might trigger or perpetuate ME/CFS symptoms?
- Why does only a subset of BDV-infected individuals develop CFS, and what cofactors determine disease susceptibility?
- Is BDV persistence or reactivation associated with CFS symptom severity or progression?
What This Study Does Not Prove
This study does not prove that BDV causes ME/CFS, nor does it establish the direction of causality (infection could be a consequence rather than cause of immune dysfunction). The lack of a healthy control group limits our ability to determine whether BDV prevalence in CFS patients differs significantly from the general population. The study cannot explain why some infected individuals develop CFS while others do not.
Tags
Symptom:Fatigue
Biomarker:AutoantibodiesBlood Biomarker
Phenotype:Infection-Triggered
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory Only
Metadata
- PMID
- 9396313
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026